The co-occurrence of CCL5 with canonical antioxidant genes such as Gpx6, NQO1, and Gclc, which are among the top-ranked VIP contributors, suggests that the transcriptomic response to MetS encompasses not only classical oxidative enzymes but also immunomodulatory and redox-regulatory mediators. The gene discussed is VIP; the disease is metabolic syndrome.